Early diagnosis and successful treatment of cytomegalovirus peritonitis in children with primary nephrotic syndrome: case series and literature review

Abstract Cytomegalovirus (CMV) is a major pathogen in immunocompromised population and CMV infections in immunocompromised patients cause substantial morbidity and mortality. The common clinical manifestations of CMV infection are pneumonia, hepatitis, colitis and so on, while CMV peritonitis without gut perforation is rare. Reviewing the literature, CMV peritonitis in patients with nephrotic syndrome (NS) had not been reported. Only four cases of CMV peritonitis without gut perforation were reported in adults with other diseases. Two cases were diagnosed by reverse-transcription polymerase chain reaction (RT-PCR) of ascites while the other two cases by histopathological examination of peritoneal tissue. We report four cases of primary nephrotic syndrome complicated with CMV peritonitis. Four cases all diagnosed by RT-PCR of ascites (659–455 000 copies/mL). We mainly discusses the diagnosis and treatment of CMV peritonitis without gut perforation.

[1]  Na Huang,et al.  Peritonitis secondary to hemorrhagic fever with renal syndrome: a case report in GuangZhou China , 2020, BMC infectious diseases.

[2]  G. Papanicolaou,et al.  CMV Prevention and Treatment in Transplantation: What’s New in 2019 , 2019, Current Infectious Disease Reports.

[3]  V. Manchanda,et al.  Incidence and risk factors for major infections in hospitalized children with nephrotic syndrome , 2019, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

[4]  A. Humar,et al.  Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice , 2019, Clinical transplantation.

[5]  G. Papanicolaou,et al.  A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  P. Niaudet,et al.  Acute kidney injury complicating nephrotic syndrome of minimal change disease. , 2018, Kidney international.

[7]  R. Goldberg,et al.  De novo CMV‐associated collapsing focal segmental glomerulosclerosis in a kidney transplant recipient , 2018, Transplant Infectious Disease.

[8]  A. Caliendo,et al.  The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation , 2010, Transplantation.

[9]  Y. Fukasawa,et al.  Cytomegalovirus peritonitis after kidney transplantation diagnosed through histopathological examination , 2017, Transplant infectious disease : an official journal of the Transplantation Society.

[10]  T. Fu,et al.  Antibody therapies for the prevention and treatment of viral infections , 2017, npj Vaccines.

[11]  A. Neumann,et al.  Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection , 2017, PLoS pathogens.

[12]  P. Jaksch,et al.  Maribavir Versus Valganciclovir for Pre-Emptive Treatment of Cytomegalovirus Viremia: A Randomized, Dose-Ranging, Phase 2 Study Among Hematopoietic Stem Cell Transplant and Solid Organ Transplant Recipients , 2017 .

[13]  S. Taghavi,et al.  Cytomegalovirus Peritonitis Without Gut Perforation But With Concomitant Colitis After a Liver Allograft Transplant. , 2015, Experimental and Clinical Transplantation.

[14]  P. Jaksch,et al.  Maribavir Versus Valganciclovir for Preemptive Treatment of Cytomegalovirus (CMV) Viremia: A Randomized, Dose-Ranging, Phase 2 Study Among Hematopoietic Stem Cell Transplant (SCT) and Solid Organ Transplant (SOT) Recipients , 2016 .

[15]  S. Hirota,et al.  Ileum perforation due to cytomegalovirus infection in a patient with adult T‐cell leukemia , 2016, Acute Medicine & Surgery.

[16]  D. Selewski,et al.  AKI in Children Hospitalized with Nephrotic Syndrome. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[17]  K. Kokko,et al.  Cytomegalovirus colitis in a critically ill, dialysis-dependent, acute kidney injury patient without immunosuppressive therapy. , 2015, Clinical Nephrology.

[18]  A. Steer,et al.  Spontaneous bacterial peritonitis as a presenting feature of nephrotic syndrome , 2013, Journal of paediatrics and child health.

[19]  G. Papanicolaou,et al.  CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. , 2013, The New England journal of medicine.

[20]  J. Mandal,et al.  Clinical spectrum and predictive risk factors of major infections in hospitalized children with nephrotic syndrome , 2013, Indian Pediatrics.

[21]  Mikiko Takikita,et al.  Ascitic fluid due to type II herpes simplex virus infection: Report of a case with immunocytochemical confirmation , 2013, Diagnostic cytopathology.

[22]  J. Cherry,et al.  Feigin and Cherry's textbook of pediatric infectious diseases , 2013 .

[23]  A. Caliendo,et al.  Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. , 2013, Transplantation.

[24]  L. Danziger-Isakov,et al.  Assessment of Cytomegalovirus Hybrid Preventative Strategy in Pediatric Heart Transplant Patients. , 2012, Journal of the Pediatric Infectious Diseases Society.

[25]  M. Van Ranst,et al.  Coxsackievirus B1 peritonitis in a patient treated with continuous ambulatory peritoneal dialysis: a case report and brief review of the literature. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[26]  D. Coen,et al.  Stereoselective Phosphorylation of Cyclopropavir by pUL97 and Competitive Inhibition by Maribavir , 2010, Antimicrobial Agents and Chemotherapy.

[27]  Angela M Caliendo,et al.  International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. , 2010, Transplantation.

[28]  A. Åsberg,et al.  Long‐Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  D. Lilleri,et al.  Prophylaxis followed by preemptive therapy versus preemptive therapy for prevention of human cytomegalovirus disease in pediatric patients undergoing liver transplantation. , 2008, Transplantation.

[30]  C. Halma,et al.  A cloudy bag and genital ulcers. , 2006, Clinical Nephrology.

[31]  S. Wann,et al.  Colon perforation with peritonitis in an acquired immunodeficiency syndrome patient due to cytomegalovirus and amoebic colitis. , 2005, Journal of the Formosan Medical Association = Taiwan yi zhi.

[32]  A. Schwarz,et al.  Cytomegalovirus peritonitis after renal transplantation under induction therapy with alemtuzumab in a young woman previously treated with peritoneal dialysis. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  C. Forsmark,et al.  Cytomegalovirus peritonitis in a patient with the acquired immunodeficiency syndrome , 1992, Digestive Diseases and Sciences.

[34]  P. Senguttuvan,et al.  Infections encountered in childhood nephrotics in a pediatric renal unit , 2004 .

[35]  B. Rath,et al.  Clinical profile of children with nephrotic syndrome not on glucorticoid therapy, but presenting with infection , 2004, Journal of paediatrics and child health.

[36]  U. Querfeld,et al.  “Sterile peritonitis” caused by varicella in a child on maintenance peritoneal dialysis treatment , 2004, Pediatric nephrology (Berlin, West).

[37]  R. Harvey,et al.  Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole l-Riboside with a Unique Mode of Action , 2002, Antimicrobial Agents and Chemotherapy.

[38]  S. Chou Cytomegalovirus drug resistance and clinical implications , 2001, Transplant infectious disease : an official journal of the Transplantation Society.

[39]  R. Ashley,et al.  Herpes simplex virus peritonitis. , 2000, Clinical Infectious Diseases.

[40]  T. F. Smith,et al.  Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation. , 2000, The Journal of infectious diseases.

[41]  T. Babinchak,et al.  Herpes simplex peritonitis: case report. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  E. Albu,et al.  Emergency Surgery for Generalized Peritonitis Caused by Cytomegalovirus Colitis in a Patient with AIDS , 1999, The American surgeon.

[43]  B. Gazzard,et al.  Summary of the II International Symposium on Cytomegalovirus. , 1998, Antiviral research.

[44]  J. Reyes,et al.  Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  R. Wyatt,et al.  The Role of I and B in Peritonitis Associated with the Nephrotic Syndrome of Childhood , 1993, Pediatric Research.

[46]  G. Goldfeld,et al.  Detection of CMV-DNA in cells from peritoneal fluid of IPD/CAPD patients by polymerase chain reaction. , 1992, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[47]  S. Lewis Recurrent peritonitis: evidence for possible viral etiology. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[48]  P. Blake,et al.  Cloudy Effluent with Atypical Lymphocytes in a CAPD Patient: Case Report , 1989, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[49]  C. Losasso,et al.  Coxsackie virus-induced acute pancreatitis in a long-term dialysis patient. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[50]  D. Struijk,et al.  Viral peritonitis in a continuous ambulatory peritoneal dialysis patient. , 1986, Nephron.

[51]  C. Blanc,et al.  Impaired IgG synthesis in patients with the nephrotic syndrome. , 1982, Clinical nephrology.

[52]  L. Schlesinger,et al.  T-cell dysfunction in minimal-change nephrotic syndrome of childhood. , 1982, American journal of diseases of children.

[53]  R. Larke,et al.  ENTEROVIRAL SYNDROMES IN TORONTO, 1964. , 1965, Canadian Medical Association journal.